Aspect Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$939 Buy
11
+1
+10% +$91 ﹤0.01% 588
2026
Q2
$917 Hold
10
– – ﹤0.01% 583
2026
Q1
$852 Sell
10
-2
-17% -$178 ﹤0.01% 617
2025
Q4
$948 Buy
+12
New +$941 ﹤0.01% 639

Other funds holding CL

Aspect Partners's CL Position: Q3 2026 in Review

Aspect Partners increased its Colgate-Palmolive (CL) stake by 10% in Q3 2026, buying an estimated $91 and bringing the position to 11 shares worth $939. The position accounts for ﹤0.01% of the portfolio, ranked #588.

Aspect Partners first reported a position in CL in Q4 2025 and has held it in 4 quarters since. The position peaked at $948 in Q4 2025. 543 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Aspect Partners held 11 shares of Colgate-Palmolive worth $939 as of Q3 2026.
  • Aspect Partners bought 1 Colgate-Palmolive share in Q3 2026, an estimated $91.
  • Colgate-Palmolive made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #588 holding.
  • Aspect Partners first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 4 quarters since.
  • Aspect Partners's Colgate-Palmolive position peaked at $948 in Q4 2025.
  • 543 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.